Sensex
82,408.17 profit arw 1,046.30 (1.29%)
Nifty
25,112.40 profit arw 319.15 (1.29%)
Nasdaq
18,355.20 profit arw -497.09 (-2.64%)
logo img

GET IN TOUCH

GET IN TOUCH

Refresh Captcha
Equity

As on : 16-Jun-2025
Hot Pursuit
16-Jun-2025     08:40

Aurobindo Pharma's US arm incorporates Cresedemo Pharma

The purpose of incorporating this new entity is to expand the company's pharmaceutical products business in USA.

The company has subscribed to a share capital of $10,000 divided into 10,000 shares with a nominal value of $1 each.

Aurobindo Pharma is an integrated global pharmaceutical company headquartered in Hyderabad, India. The company develops, manufactures, and commercializes a wide range of generic pharmaceuticals, branded specialty pharmaceuticals and active pharmaceutical ingredients globally in over 150 countries.

The company's consolidated net profit fell 0.6% to Rs 903.47 crore despite a 11.9% jump in net sales to Rs 8,381.12 crore in Q4 FY25 over Q4 FY24.

The scrip declined 0.38% to end at Rs 1,150.65 on the BSE.

Powered by Capital Market - Live News

INDIAN INDICES

Sensex

82,408.17 1,046.30 (1.29%)

Nifty

25,112.40 319.15 (1.29%)

GLOBAL INDICES

USD

85.75 0.06 (0.95%)

NASDAQ
HANG SENG

23,530.49 292.74(1.26%)